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A 43-year-old man with linear immunoglobulin A (IgA) dermatosis associated with gluten intolerance presented with progressive
vision loss, pain and photosensitivity in both eyes. His visual acuity was light perception (LP) in both eyes. A physical examination
revealed bullous, papular lesions with erythematous borders in periocular tissues, limbs, and thorax. Slit-lamp examination
showed conjunctival hyperemia, ﬁbrosis, corneal opaciﬁcation, and vascularization with epithelial defects. Immunoﬂuorescent
skin and corneal surface biopsy studies showed linear IgA deposits. The patient was treated with keratolimbal allogenic
transplantation and cryopreserved amniotic membrane in the right eye. Regardless of the treatment he persisted with torpid
evolutiondevelopingretinalandchoroidaldetachments.Aftertheseeventshewasstartedonintravenousimmuneglobulin(IVIG)
and showed very slight improvement in ocular surface. These types of blistering diseases are rare in the eye. Even when adequate
local treatment is given, systemic treatment is mandatory and ocular prognosis can be unsatisfactory.
1.Introduction
Linear IgA dermatosis (LAD) is an autoimmune epidermal
disorder that may aﬀect skin and mucous membranes [1].
Dermatosis can be recurrent and produce purulent lesions
associated with bullae or vesicles [2]. This is a rare bullous
disease with ophthalmologic manifestations characterized
by dry eye, foreign body sensation, conjunctival scarring
with trichiasis, entropion, corneal opaciﬁcation, neovas-
cularization, and potential blindness [3]. This pathology
can be diﬃcult to distinguish from other scarring diseases
such as ocular cicatricial pemphigoid [4]. To conﬁrm the
diagnosis, a skin biopsy must show deposits of IgA in a linear
distributionoverthejunctionbetweendermisandepidermis
[2].
We describe a case of chronic cicatrizing conjunctivi-
tis associated with gluten intolerance and dermatological
involvement. Skin biopsy specimens underwent immunoﬂu-
orescence, conﬁrming LAD.
2.CaseReport
A43-year-oldmanwitha5-yearhistoryofglutenintolerance
and bullous dermatosis had been treated for recurrent
conjunctivitis. He came to us with progressive vision loss,
photosensitivity, foreign body sensation, and burning sen-
sation in both eyes. He presented bullous and papular
lesions with erythematous base in periocular tissues, limbs,
thorax (Figure 1). Two years before, a previous diagnosis of
dermatitisherpetiformisinanothercenterwasgivenandwas
treated with 50mg per day of oral dapsone and 5mg per day
of oral prednisolone.
The visual acuity was light perception in each eye.
Slit lamp examination showed dysfunctional meibomian2 Journal of Ophthalmology
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Figure 1: Patient with multiple dermatologic lesions distributed in
limbs (a) and back (b).
glands, conjunctival hyperemia, subconjcuntival ﬁbrosis,
corneal superﬁcial vascularization, and opaciﬁcation with
epithelial defects, and the rest of the anterior segment was
diﬃcult to evaluate (Figure 2). The ocular ultrasound was
unremarkable in both eyes. A histopathological examination
of the skin biopsy revealed neutrophil alignment along basal
membrane and subepidermal cleavage with inﬂammatory
cells in the superﬁcial dermis; immunoﬂuorescence con-
ﬁrmed IgA deposits along the basal membrane (Figure 3(a)).
We decided to continue with dapsone and started him
on a topical erythromycin ointment, lubricants, 50mg per
day of systemic prednisolone, 50mg per day of sulfone,
and 75mg daily of azathioprine. A keratolimbal allograft
transplantation was performed, with superﬁcial keratectomy
that underwent histopathological studies. We observed a
complete destruction of Bowman’s layer, replaced by ﬁbrotic
tissue with perforant vessels, and immunoﬂuorescence stud-
ies conﬁrmed IgA deposits over this area (Figure 3(b)).
A monolayer of cryopreserved amniotic membrane was
implanted in his right eye. We suggested immunoglobulin
therapy, but the patient could not obtain the treatment.
Four months after the surgery, a corneal melt was noted and
eventually he needed two more amniotic membrane patches
for immanent perforation. Unfortunately he persisted with
torpid evolution and the right eye visual acuity displayed
LP without color discrimination and the ultrasound showed
retinal and choroidal detachments (Figure 4). The left eye
was not treated surgically and the visual acuity slightly
improved to hand motion. Although dermatologic lesions
improved signiﬁcantly after IVIG therapy (Figure 5(a)),
unyielding, severe ocular surface disease persisted (Figures
5(b) and 5(c)).
3. Discussion
We presented a case of IgA linear dermatosis with a very
severe ocular and predominantly corneal aﬀection. Although
there are case reports of LAD without skin or mucous
membrane involvement, the predominant dermatologic
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Figure 2: Right eye (a) and left eye (c) showing subconjunctival
ﬁbrosis, corneal opacities and vascularization as well epithelial
defects. Right eye upper tarsal conjunctiva with ﬁbrosis (b) and left
eye (d) lower tarsal conjunctiva with subepithelial ﬁbrosis.Journal of Ophthalmology 3
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Figure 3: Immunoﬂuorescence showing skin (A). Aﬀected cornea
(B) showing IgA deposits along the basal membrane and Bowman’s
layer (arrow) with inﬂammatory inﬁltrates (asterisk) and blood
vessels (arrowheads). Comparison with healthy cornea tissue (C)
showing intact Bowman’s layer (arrow) and stroma (S). (Micro-
graph A, 400X; B, 100X, counterstain Propidium iodide).
ﬁndings in this case prompted our diagnostic consideration
of LAD [1, 3].
The dermatologic lesions resembling LAD are dermatitis
herpetiformis, pemphigoid, epidermolysis bullosa acquisita,
and ocular pemphigus vulgaris. The diﬀerences between
these diseases was deﬁned almost thirty years ago [2, 5, 6].
The bullous diseases develop ocular manifestations usually
resistant to surgical and medical treatments. In this case,
despite good compliance and multidisciplinary approach,
the ocular outcome was catastrophic [4].
The average incidence is around 0.58 cases per 200,000
individuals. Previous reports indicate severe ocular aﬀection
and progression in men, thus the presence of ocular disease
can be more aggressive in the masculine gender such as in
this case [6]. Nevertheless LAD also aﬀects the female and
pediatric population [7].
In this case there were no previous medications or vacci-
nations associated with drug-induced linear IgA dermatosis
[8, 9].
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Figure 4: Right eye ultrasound B-scan with both retinal (asterisks)
and choroidal (arrow) detachments.
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Figure 5: Dermatological lesions improved after treatment (a).
Right eye (b) and left eye (c) ocular surface photographs after initial
IVIG treatment.
Despite that, theoretically, end-stage disease is rare in
LAD [9], and even though we treated the patient with
systemicimmunosuppressionagentsandsurgicalprocedures
the ocular response was very poor. There are previous
reports of corneal perforations [1, 4]a n dt h eu s eo fc o r n e a l
transplantation and limbal stem cell grafts [4], but in those
cases the outcomes were also unsatisfactory.
To our knowledge, there are no previous reports about
the use of amniotic membrane in this disease, but after the
outcome of our patient, it is hard to know how useful or
dangerous it can be in these kinds of cases.
Based on evidence that the basement membrane type
IV collagen is a target for the IgA autoantibodies in other
tissues [10], we performed and were able to elicit posi-
tive immunoﬂorescence studies on the corneal epithelium.4 Journal of Ophthalmology
We therefore suppose that type IV collagen of corneal
epithelium, Bowman’s membrane may be an IgA auto
antibody target in cases of LAD.
Even though up to 50% of the patients with LAD
presented ocular involvement [1, 2, 6, 9, 11], there is scanty
literature in the ophthalmologic ﬁeld [2, 4, 11].
Unlike dermatitis herpetiformis and other dermatologic
conditions which are linked to gluten enteropathy, LAD is
not associated with gluten intake [2]. The patient used to
avoid gluten in his diet but patients with LAD tend to not
respond to a diet free of gluten as in other dermatological
diseases [2, 12].
Despite the fact that patients with LAD can respond to
IVIG [3], in severe cases like this patient, it is hard to expect
an evident respond.
In conclusion linear IgA can be a devastating problem
for the ocular surface. As ophthalmologists, we need to be
prepared for these scenarios and be aware of the unfavorable
presentations of this disease.
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